Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease GlobeNewswire - Mon Jan 6, 7:00AM CST

FBIO : 1.8800 (-0.79%)
FBIOP : 7.00 (+2.94%)
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) GlobeNewswire - Fri Dec 13, 2024

FBIO : 1.8800 (-0.79%)
CKPT : 3.31 (+4.42%)
Fortress Biotech Announces FDA Approval of Emrosi for Rosacea Treatment and Details Upcoming PDUFA for Cosibelimab Quiver Quantitative, Inc. - Fri Nov 15, 2024

Fortress Biotech announced FDA approval for Emrosi for rosacea and a PDUFA date for cosibelimab. Financial results show a net loss.Quiver AI SummaryFortress Biotech, Inc. announced that its product Emrosi,...

FBIO : 1.8800 (-0.79%)
Fortress Biotech: Q3 Earnings Snapshot AP - Thu Nov 14, 2024

Fortress Biotech: Q3 Earnings Snapshot

FBIO : 1.8800 (-0.79%)
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights GlobeNewswire - Thu Nov 14, 2024

FBIO : 1.8800 (-0.79%)
FBIOP : 7.00 (+2.94%)
Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates GlobeNewswire - Tue Nov 12, 2024

FBIO : 1.8800 (-0.79%)
CKPT : 3.31 (+4.42%)
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights GlobeNewswire - Tue Nov 12, 2024

FBIO : 1.8800 (-0.79%)
DERM : 3.90 (+4.56%)
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea GlobeNewswire - Mon Nov 4, 2024

FBIO : 1.8800 (-0.79%)
DERM : 3.90 (+4.56%)
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference GlobeNewswire - Fri Oct 25, 2024

FBIO : 1.8800 (-0.79%)
DERM : 3.90 (+4.56%)
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit GlobeNewswire - Wed Oct 9, 2024

FBIO : 1.8800 (-0.79%)
ATXI : 1.9100 (+1.60%)

Barchart Exclusives

D-Wave’s Largest Investor Is Giving Up on QBTS Stock. Should You? Barchart - 1 hour ago
According to SEC filings, the Public Sector Pension Investment Board plans to sell all of its QBTS stock holdings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot